Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Established and novel NF-?B inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC.

Established and novel NF-?B inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol. 2011 Sep; 47(9):818-26.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.